ELDON BIOLOGICALS A/S: Financial statements 2014
CVR: 26747007
Source: annual report 2014, Danish Business Authority
01/07/2013 – 30/06/2014
ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 4,901,318 and a net result of DKK 1,067,436 compared with DKK 948,720 the year before. That is an increase of 19.8% compared with the year before. Equity in the 2014 report amounted to DKK -1,182,839.
- Gross Profit
- DKK 4,901,318
- Profit/Loss
- DKK 1,067,436
- Equity
- DKK -1,182,839
- Total Assets
- DKK 4,899,262
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 4.9 mio. | 1.1 mio. | -1.2 mio. | - |
| 2013 | - | 4.1 mio. | 949 t. | -2.3 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of September 2, 2014, REVISIONSFIRMAET SLEIMANN ApS has been appointed auditor of ELDON BIOLOGICALS A/S.
As of September 2, 2014, V & CO STATSAUTORISERET REVISIONSANPARTSSELSKAB has stepped down as auditor of ELDON BIOLOGICALS A/S.
About ELDON BIOLOGICALS A/S
ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The board consists of Michael Lützhøft Hansen (chair), Cara Beth Seiderman and Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity in the 2025 report amounted to DKK 42,055,949.